Patent · US Active

Binding protein of NS1 protein

US12291564B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

Fapon Biotech Inc. · CN

Inventors

Peng Cui · Suwon-si, KR
Zhiqiang He · Nanhu, CN
Yuan Meng · Rochester, US
Dongmei ZHONG · Dongguan, CN

Key dates

Filing date	Aug 26, 2019
Grant date	May 6, 2025
Priority date	—
Expiry date	Jan 24, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Provided is an isolated binding protein including an antigen-binding domain that binds to NS1 protein. The isolated binding protein includes specific heavy chain CDRs and light chain CDRs. The binding protein can specifically recognize and bind to NS1, and has relatively high sensitivity and specificity, thereby achieving the detection of dengue virus. Moreover, the binding protein is not required to be produced by inducing hybridoma cells in mouse abdominal cavity, and thus it is simple in production and has more stable antibody function.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.